Wednesday, 6 March 2019

Vertex's cystic fibrosis therapy meets goal of late-stage studies

Vertex Pharmaceuticals Inc said on Wednesday its triple-combination therapy showed improvement in lung function for people with cystic fibrosis (CF).


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)